George E. Pentheroudakis

Ioannina, ESYE21 45500, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 324 publications

Anti-EGFR re-challenge with chemotherapy in RAS wild-type advanced colorectal cancer (A-REPEAT study): efficacy and correlations with tissue and plasma genotyping.

Anti-EGFR re-challenge with chemotherapy in RAS wild-type advanced colorectal cancer (A-REPEAT study): efficacy and correlations with tissue and plasma genotyping.

Journal: ESMO gastrointestinal oncology

Published: February 06, 2026

Feasibility and impact of Lynch syndrome genetic testing in newly diagnosed colorectal cancer patients: a multicenter observational study in Greece.

Feasibility and impact of Lynch syndrome genetic testing in newly diagnosed colorectal cancer patients: a multicenter observational study in Greece.

Journal: ESMO gastrointestinal oncology

Published: February 06, 2026

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment, and follow-up of patients with hepatocellular carcinoma.

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment, and follow-up of patients with hepatocellular carcinoma.

Journal: ESMO open

Published: December 02, 2025

ESMO-ESTRO consensus statements on the safety of combining radiotherapy with CDK4/6, HER2, PARP, or mTOR inhibitors.

ESMO-ESTRO consensus statements on the safety of combining radiotherapy with CDK4/6, HER2, PARP, or mTOR inhibitors.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: November 25, 2025

Assessing Overall Survival Benefits in Advanced Cancers: The Role of External Comparator Cohort Studies with Real-World Data.

Assessing Overall Survival Benefits in Advanced Cancers: The Role of External Comparator Cohort Studies with Real-World Data.

Journal: Clinical pharmacology and therapeutics

Published: November 08, 2025

ESMO-ESTRO consensus statements on the safety of combining radiotherapy with EGFR, ALK, or BRAF/MEK inhibitors.

ESMO-ESTRO consensus statements on the safety of combining radiotherapy with EGFR, ALK, or BRAF/MEK inhibitors.

Journal: ESMO open

Published: October 28, 2025

ESMO Adaptation of Lines of Systemic Therapy (EnLiST): a consensus framework for standardising the designation of lines of therapy in solid tumours.

ESMO Adaptation of Lines of Systemic Therapy (EnLiST): a consensus framework for standardising the designation of lines of therapy in solid tumours.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: October 10, 2025

ESMO adaptation of Lines of Systemic Therapy (EnLiST): a consensus framework for standardising the designation of lines of therapy in solid tumours.

ESMO adaptation of Lines of Systemic Therapy (EnLiST): a consensus framework for standardising the designation of lines of therapy in solid tumours.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: October 10, 2025

ESMO Clinical Practice Guideline Express Update on the adoption of physical exercise in patients with localised colon cancer.

ESMO Clinical Practice Guideline Express Update on the adoption of physical exercise in patients with localised colon cancer.

Journal: ESMO open

Published: September 30, 2025

ESMO basic requirements for AI-based biomarkers in oncology (EBAI).

ESMO basic requirements for AI-based biomarkers in oncology (EBAI).

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: September 16, 2025

Evaluation of ct-DNA and mutational status in liquid biopsy of patients with metastatic colorectal cancer.

Evaluation of ct-DNA and mutational status in liquid biopsy of patients with metastatic colorectal cancer.

Journal: Oncology letters

Published: July 28, 2025

Updated treatment recommendations for systemic treatment: from the ESMO Metastatic Breast Cancer Living Guideline.

Updated treatment recommendations for systemic treatment: from the ESMO Metastatic Breast Cancer Living Guideline.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: July 07, 2025

Showing 1-12 of 324

Last Updated: 09/26/2026